JPH0262543B2 - - Google Patents

Info

Publication number
JPH0262543B2
JPH0262543B2 JP61007824A JP782486A JPH0262543B2 JP H0262543 B2 JPH0262543 B2 JP H0262543B2 JP 61007824 A JP61007824 A JP 61007824A JP 782486 A JP782486 A JP 782486A JP H0262543 B2 JPH0262543 B2 JP H0262543B2
Authority
JP
Japan
Prior art keywords
group
formula
hydroxy
carbon atoms
cyclobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61007824A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61197548A (ja
Inventor
Rojindeeru Hausurii Jon
Edowaado Jefurei Jeemusu
Nooman Jonsuton Debitsudo
Jeremii Saajento Buruusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPS61197548A publication Critical patent/JPS61197548A/ja
Publication of JPH0262543B2 publication Critical patent/JPH0262543B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/567—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Physical Vapour Deposition (AREA)
  • Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
JP61007824A 1985-01-17 1986-01-17 治療剤 Granted JPS61197548A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858501192A GB8501192D0 (en) 1985-01-17 1985-01-17 Therapeutic agents
GB8501192 1985-01-17

Publications (2)

Publication Number Publication Date
JPS61197548A JPS61197548A (ja) 1986-09-01
JPH0262543B2 true JPH0262543B2 (enEXAMPLES) 1990-12-26

Family

ID=10572997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61007824A Granted JPS61197548A (ja) 1985-01-17 1986-01-17 治療剤

Country Status (27)

Country Link
US (2) US4925879A (enEXAMPLES)
EP (1) EP0191542B1 (enEXAMPLES)
JP (1) JPS61197548A (enEXAMPLES)
CN (1) CN1012733B (enEXAMPLES)
AT (1) ATE34976T1 (enEXAMPLES)
AU (1) AU591390B2 (enEXAMPLES)
CS (3) CS258138B2 (enEXAMPLES)
DD (3) DD267727A5 (enEXAMPLES)
DE (1) DE3660286D1 (enEXAMPLES)
DK (1) DK5386A (enEXAMPLES)
ES (3) ES8706608A1 (enEXAMPLES)
FI (1) FI860111A7 (enEXAMPLES)
GB (1) GB8501192D0 (enEXAMPLES)
GR (1) GR860092B (enEXAMPLES)
HU (1) HUT41713A (enEXAMPLES)
IL (1) IL77452A (enEXAMPLES)
IN (1) IN162780B (enEXAMPLES)
JO (1) JO1438B1 (enEXAMPLES)
NO (1) NO163855C (enEXAMPLES)
NZ (1) NZ214787A (enEXAMPLES)
PH (1) PH25979A (enEXAMPLES)
PL (3) PL148185B1 (enEXAMPLES)
PT (1) PT81855B (enEXAMPLES)
RO (1) RO93855A (enEXAMPLES)
YU (3) YU4686A (enEXAMPLES)
ZA (1) ZA86262B (enEXAMPLES)
ZW (1) ZW24085A1 (enEXAMPLES)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
GB9127306D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9309749D0 (en) * 1993-05-12 1993-06-23 Boots Co Plc Therapeutic agents
PL177947B1 (pl) * 1993-06-22 2000-02-29 Knoll Ag Nowe związki tetrahydroizochinolinowe, kompozycja farmaceutyczna i sposób wytwarzania nowych związków tetrahydroizochinolinowych
GB9524681D0 (en) * 1995-12-02 1996-01-31 Knoll Ag Chemical process
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002036540A2 (en) * 2000-11-02 2002-05-10 Torrent Pharmaceuticals Ltd PROCESS FOR PREPARATION OF β-PHENETHYLAMINE DERIVATIVE
US20020115727A1 (en) * 2000-12-04 2002-08-22 Senanayake Chris H. Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
US20030087963A1 (en) * 2001-09-13 2003-05-08 Senanayake Chris H. Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
EP1828096A2 (en) * 2004-12-22 2007-09-05 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Enantioselective synthesis of a sterically hindered amine
JP2007229046A (ja) * 2006-02-28 2007-09-13 Hitachi Ltd 磁場補正装置
RU2462451C2 (ru) * 2006-09-15 2012-09-27 Ривайва Фармасьютикалс, Инк. Способ получения, способы применения и композиции циклоалкилметиламинов
JP5513508B2 (ja) * 2008-09-10 2014-06-04 セルジーン コーポレイション アミノスルホン化合物を調製するためのプロセス
WO2012003501A2 (en) * 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
MX352874B (es) * 2011-12-30 2017-12-13 Reviva Pharmaceuticals Inc Composiciones, sintesis, y metodos para usar derivados de fenilcicloalquilmetilamina.
CN102786444A (zh) * 2012-07-24 2012-11-21 上海瑞博化学有限公司 一种西布曲明类似物的磺酸盐的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565592A (en) * 1948-02-27 1951-08-28 Merck & Co Inc 3-hydroxy-4, 4-diphenyl-6-aminoheptanes
US3054822A (en) * 1959-11-27 1962-09-18 Hoechst Ag Benzyl substituted propylamines
DE1124485B (de) * 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
US3573304A (en) * 1968-12-03 1971-03-30 Delalande Sa 1-dimethylamino - 3 - methyl-2(pyridyl or pyridazinyl) pentane and the corresponding non-toxic acid addition salts thereof
US3706764A (en) * 1969-04-16 1972-12-19 Yoshitomi Pharmaceutical Phenethylaminomethyl-chromanones and- thiochromanones
BE757408A (fr) * 1969-10-13 1971-04-13 Thomae Gmbh Dr K Nouveaux butanols tertiaires a constituants basiques
SE7600674L (sv) * 1975-02-05 1976-08-06 Rohm & Haas Fungicider
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
US4443449A (en) * 1981-04-06 1984-04-17 The Boots Company Limited Arylcyclobutylalkylamines and anti-depression composition and methods using same
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
DK101683A (da) * 1982-03-12 1983-09-13 Duphar Int Res Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
IE56001B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylmethylamine compounds
IE56324B1 (en) * 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
ES8801617A1 (es) 1988-02-16
HUT41713A (en) 1987-05-28
NO855204L (no) 1986-07-18
EP0191542B1 (en) 1988-06-08
IL77452A0 (en) 1986-08-31
DK5386D0 (da) 1986-01-07
EP0191542A1 (en) 1986-08-20
CS34286A2 (en) 1987-11-12
PH25979A (en) 1992-01-13
FI860111A0 (fi) 1986-01-10
US4925879A (en) 1990-05-15
PT81855A (en) 1986-02-01
JO1438B1 (en) 1988-03-10
CN86100954A (zh) 1986-09-03
NO163855B (no) 1990-04-23
NZ214787A (en) 1989-07-27
CS258150B2 (en) 1988-07-15
ES550933A0 (es) 1987-07-01
AU5172585A (en) 1986-07-24
IN162780B (enEXAMPLES) 1988-07-09
ES557445A0 (es) 1988-02-16
PL148185B1 (en) 1989-09-30
ES557444A0 (es) 1988-02-16
PL262502A1 (en) 1987-09-21
DD267728A5 (de) 1989-05-10
PL148184B1 (en) 1989-09-30
RO93855A (ro) 1988-02-29
CS258149B2 (en) 1988-07-15
NO163855C (no) 1990-08-01
YU139587A (en) 1988-04-30
PL257486A1 (en) 1987-03-23
CS258138B2 (en) 1988-07-15
CS89587A2 (en) 1987-11-12
ES8706608A1 (es) 1987-07-01
PT81855B (pt) 1987-11-30
JPS61197548A (ja) 1986-09-01
DE3660286D1 (en) 1988-07-14
ES8801618A1 (es) 1988-02-16
PL146910B1 (en) 1989-03-31
PL262501A1 (en) 1987-09-21
US5047432A (en) 1991-09-10
GB8501192D0 (en) 1985-02-20
CN1012733B (zh) 1991-06-05
DD267727A5 (de) 1989-05-10
CS89687A2 (en) 1987-11-12
YU139687A (en) 1988-04-30
IL77452A (en) 1991-08-16
DD258004A5 (de) 1988-07-06
DK5386A (da) 1986-07-18
YU4686A (en) 1988-04-30
ATE34976T1 (de) 1988-06-15
FI860111A7 (fi) 1986-07-18
AU591390B2 (en) 1989-11-30
ZA86262B (en) 1986-08-27
GR860092B (en) 1986-05-14
ZW24085A1 (en) 1986-08-27

Similar Documents

Publication Publication Date Title
JPH0262543B2 (enEXAMPLES)
US7166592B2 (en) Nonsteroidal antiinflammatory agents
JP3255421B2 (ja) ニューロキニンアンタゴニストとしての置換されたオキシム、ヒドラゾンおよびオレフィン
KR100524159B1 (ko) 모노아민 재흡수 억제제로서 유용한 비아릴 에테르 유도체
TWI254038B (en) N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
JPH0415216B2 (enEXAMPLES)
JPH10508870A (ja) カンナビノイド受容体への親和性を有するインドール誘導体
NL8201347A (nl) Aromatische verbindingen, therapeutische preparaten die ze bevatten en werkwijzen voor het bereiden van deze verbindingen en therapeutische preparaten.
WO2005000778A1 (ja) Hsp90ファミリー蛋白質阻害剤
PT93753B (pt) Processo para a preparacao de compostos azabiciclicos
IL136723A (en) Arylpiperazines are active in serotonin A1 receptors
IL112097A (en) N- (POLYHYDRO- OXACYCLOALKANO £2, 3-g| INDOL-1-YLALKYL) (CYCLO) ALKANANILIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUT72082A (en) Substituted triols, pharmaceutical compositions containing them and process for their production
TW200304815A (en) NK1 antagonists
CN104781245A (zh) 用于生产二氢-2h-吡喃衍生物的方法
TW201240973A (en) Heterocyclic compound
NZ196086A (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives and pharmaceutical compositions
KR900005256B1 (ko) 페닐사이클로부틸메틸아민 유도체의 제조방법
JPH07505402A (ja) ５−ｈｔ↓１様アゴニストとしてのインドール誘導体
JPH03206084A (ja) 複素環薬剤化合物及びその調製法と用途
JPH05504769A (ja) ４，５―シクロアルカノ―３―ベンズアゼピン―７―オール誘導体およびその使用
JPH05320103A (ja) プロパンアミンおよびその治療用とくに止瀉用医薬組成物
CA1335816C (en) 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
JPH07138214A (ja) 置換アミド酸誘導体
JP2006504792A (ja) Ｉ．ａ．ｈｉｖの治療における逆転写酵素変調剤として使用の４−（３，５−ジシアノフェノキシ）ピラゾール誘導体

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees